1. Hemangioblastoma: An Unsuspected Pitfall in PSMA PET/CT
- Author
-
Patrice Jissendi Tchofo, Kim Entezari, Diana Ene, Marianne Tondeur, Marie-Lucie Racu, Isabelle Salmon, and Nicolas Gohimont
- Subjects
Biochemical recurrence ,Glutamate Carboxypeptidase II ,Male ,Pathology ,medicine.medical_specialty ,Posterior fossa ,urologic and male genital diseases ,030218 nuclear medicine & medical imaging ,03 medical and health sciences ,Prostate cancer ,0302 clinical medicine ,Antigen ,Hemangioblastoma ,Positron Emission Tomography Computed Tomography ,medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,Psma pet ct ,Cerebellar Neoplasms ,Pathological ,Aged ,business.industry ,General Medicine ,medicine.disease ,Benign Vascular Neoplasm ,Gene Expression Regulation, Neoplastic ,030220 oncology & carcinogenesis ,Antigens, Surface ,business - Abstract
Hemangioblastoma (HB) is the most common primary intra-axial posterior fossa tumor in adults and is a benign vascular neoplasm. We report the case of a 73-year-old man suffering from biochemical recurrence of prostate cancer where intense overexpression of prostate-specific membrane antigen (PSMA) was observed in HB in a PSMA PET/CT. Overexpression of PSMA in tumor-associated vascular structures has been proposed as an explanation of PSMA ligand uptake in several nonprostatic tumors. Given the pathological nature of HB, this mechanism may explain the intense overexpression of PSMA observed in present case.
- Published
- 2021